US Stem Cell Inc (USRM)

[Dragon Lady]

PR indicates that the "terms" of the new "credit line" are those already outlined in the previous released 8-K filing. (that's my read on the PR)

If that's the case, then Magna is getting shares at the most for 1 CENT and possibly lower if one reads all the details in the 8-K "exhibits", which are quite lengthy.

So, if the entire line were tapped over 24 months for the full $3 million- that's a huge pile of dilution. (now one can see why the authorized went to 2 BILLION shares IMO)

Lets say they're at 1 CENT.

$3,000,000 / .01 = 300,000,000. Yep. 300 MILLION more shares of dilution, at a minimum in the next 24 months. That would pretty much push um over the 1 BILLION share mark IMO. Wow.

$3 mil /2 = $1.5 mil per yr tops they can draw down. That's $1.5/ 12 = $125,000 or $125K per month, max. That's not phase II/III "trial" level money IMO. That, pretty much covers their present salaries, expenses and so forth in just their recent SEC filings. It's like their burn rate right about now.

Just Tomas base salary and bonus + Comella base salary + bonus = $525K + $500K + $250K + $300K = $1,575,000 PER YEAR. Not even covered by this credit line amount. So what's gonna be left for funding "trials" to any serious degree?

Not seeing it IMO. A LOT of dilution and just keeps the salaries going and expenses paid (interest on other debt, loans, etc), IMO. Not much new here I can see. My 2 cents.